Heartflow (NASDAQ:HTFL) CEO John C.M. Farquhar Sells 15,560 Shares

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 15,560 shares of the business’s stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $39.06, for a total transaction of $607,773.60. Following the completion of the sale, the chief executive officer owned 420,720 shares in the company, valued at $16,433,323.20. This represents a 3.57% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Monday, August 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.31, for a total transaction of $638,730.22.
• On Friday, July 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $27.75, for a total transaction of $626,095.50.
• On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The shares were sold at an average price of $35.00, for a total transaction of $1,361,500.00.
• On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $28.50, for a total transaction of $643,017.00.

Heartflow Price Performance

Shares of Heartflow stock opened at $45.23 on Wednesday. Heartflow, Inc. has a 1 year low of $20.13 and a 1 year high of $45.33. The business has a 50 day moving average price of $29.68 and a 200 day moving average price of $27.95. The company has a market capitalization of $3.90 billion and a P/E ratio of -24.72.

Heartflow (NASDAQ:HTFL) last announced its earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.50% and a negative net margin of 55.82%.The firm had revenue of $64.08 million for the quarter. The company’s revenue was up 47.7% on a year-over-year basis. As a group, research analysts expect that Heartflow, Inc. will post -0.82 EPS for the current fiscal year.

Institutional Investors Weigh In On Heartflow

A number of institutional investors have recently bought and sold shares of HTFL. TrueMark Investments LLC increased its position in Heartflow by 1.4% during the first quarter. TrueMark Investments LLC now owns 26,885 shares of the company’s stock worth $654,000 after purchasing an additional 379 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new position in shares of Heartflow in the 4th quarter valued at $27,000. Strs Ohio grew its stake in shares of Heartflow by 35.3% during the 1st quarter. Strs Ohio now owns 4,600 shares of the company’s stock valued at $112,000 after buying an additional 1,200 shares during the period. Russell Investments Group Ltd. acquired a new stake in shares of Heartflow during the 4th quarter worth $45,000. Finally, Legal & General Group Plc purchased a new position in shares of Heartflow in the 3rd quarter worth $59,000.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on HTFL shares. Freedom Capital raised shares of Heartflow to a “strong-buy” rating in a research note on Tuesday, June 30th. Canaccord Genuity Group lifted their target price on shares of Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a research note on Friday. Morgan Stanley boosted their price target on Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a report on Friday. Piper Sandler reissued an “overweight” rating and set a $45.00 price target (up from $38.00) on shares of Heartflow in a research note on Friday. Finally, Robert W. Baird set a $45.00 price objective on Heartflow in a report on Friday. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $43.43.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.